Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial.
Mehran R, Lansky AJ, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Kornowski R, Hartmann F, Gersh BJ, Pocock SJ, Wong SC, Nikolsky E, Gambone L, Vandertie L, Parise H, Dangas GD, Stone GW; HORIZONS-AMI Trial Investigators. Mehran R, et al. Among authors: vandertie l. Lancet. 2009 Oct 3;374(9696):1149-59. doi: 10.1016/S0140-6736(09)61484-7. Epub 2009 Aug 28. Lancet. 2009. PMID: 19717185 Clinical Trial.
Implications of the presence and length of "geographic miss" on restenosis and the edge phenomenon in the INHIBIT trial.
Costantini CO, Lansky AJ, Mintz GS, Shirai K, Teirstein PS, Stone G, Vandertie L, Proctor B, Fahy M, Yeung A, Raizner AE, Waksman R, Leon MB; INHIBIT trial. Costantini CO, et al. Among authors: vandertie l. Am J Cardiol. 2003 May 15;91(10):1261-5. doi: 10.1016/s0002-9149(03)00280-7. Am J Cardiol. 2003. PMID: 12745117 Clinical Trial. No abstract available.
Feasibility and efficacy of tandem positioning on angiographic and clinical outcomes in the Intimal Hyperplasia Inhibition with Beta In-Stent Trial.
Shirai K, Lansky AJ, Mintz GS, Costantini CO, Cristea E, Fahy M, Vandertie L, Yeung A, Raizner AE, Waksman R, Leon MB. Shirai K, et al. Among authors: vandertie l. Am J Cardiol. 2003 May 1;91(9):1113-5. doi: 10.1016/s0002-9149(03)00160-7. Am J Cardiol. 2003. PMID: 12714158 Clinical Trial. No abstract available.
Inhibition of restenosis with beta-emitting radiotherapy: Report of the Proliferation Reduction with Vascular Energy Trial (PREVENT).
Raizner AE, Oesterle SN, Waksman R, Serruys PW, Colombo A, Lim YL, Yeung AC, van der Giessen WJ, Vandertie L, Chiu JK, White LR, Fitzgerald PJ, Kaluza GL, Ali NM. Raizner AE, et al. Among authors: vandertie l. Circulation. 2000 Aug 29;102(9):951-8. doi: 10.1161/01.cir.102.9.951. Circulation. 2000. PMID: 10961957 Clinical Trial.
1-Year Clinical Outcomes of All-Comer Patients Treated With the Dual-Therapy COMBO Stent: Primary Results of the COMBO Collaboration.
de Winter RJ, Chandrasekhar J, Kalkman DN, Aquino MB, Woudstra P, Beijk MA, Sartori S, Baber U, Tijssen JG, Koch KT, Dangas GD, Colombo A, Mehran R; MASCOT; REMEDEE Registry Investigators. de Winter RJ, et al. JACC Cardiovasc Interv. 2018 Oct 8;11(19):1969-1978. doi: 10.1016/j.jcin.2018.04.038. JACC Cardiovasc Interv. 2018. PMID: 30286855 Free article. Clinical Trial.